We are live on
!
Find out more
CI
Capital International Portfolio holdings
AUM
$2.7B
1-Year Est. Return
31.08%
This Fund
S&P 500
This Quarter
Est. Return
+2.82%
1 Year Est. Return
+31.08%
3 Year Est. Return
+123.92%
5 Year Est. Return
+171.61%
10 Year Est. Return
+862.17%
AUM
$1.62B
AUM Growth
–
Cap. Flow
+$1.63B
Cap. Flow
% of AUM
100.36%
Top 10 Holdings %
Top 10 Hldgs %
32.92%
Holding
161
New
161
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$129M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$67.1M |
| 3 |
Goldman Sachs
GS
|
+$50.7M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$46.1M |
| 5 |
Halliburton
HAL
|
+$45.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 14.03% |
| 3 | Energy | 12.45% |
| 4 | Consumer Discretionary | 9.5% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$167B
| $127M | 7.84% |
+2,482,000
| New | +$129M |
|
|
2
Bristol-Myers Squibb
BMY
$124B
| $69.1M | 4.26% |
+1,545,100
| New | +$67.1M |
|
|
3
Goldman Sachs
GS
$314B
| $50.3M | 3.1% |
+332,300
| New | +$50.7M |
|
|
4
Alphabet (Google) Class C
GOOG
$4.22T
| $47.8M | 2.95% |
+2,178,776
| New | +$46.1M |
|
|
5
Halliburton
HAL
$29.4B
| $45.7M | 2.82% |
+1,095,300
| New | +$45.8M |
|
6
Chevron
CVX
$373B
| $41.7M | 2.57% |
+352,129
| New | +$42.6M |
|
7
Danaher
DHR
$144B
| $40.6M | 2.5% |
+953,849
| New | +$39.5M |
|
8
CME Group
CME
$88.5B
| $39.2M | 2.42% |
+516,027
| New | +$33.9M |
|
9
Eaton
ETN
$155B
| $38.3M | 2.36% |
+582,200
| New | +$36.7M |
|
10
Truist Financial
TFC
$65.4B
| $34.1M | 2.11% |
+1,007,600
| New | +$32.1M |
|
11
Cenovus Energy
CVE
$52.1B
| $31.5M | 1.94% |
+1,107,200
| New | +$32.7M |
|
12
Apple
AAPL
$4.9T
| $31.2M | 1.93% |
+2,207,016
| New | +$34M |
|
13
Oracle
ORCL
$364B
| $31.2M | 1.92% |
+1,015,100
| New | +$33.7M |
|
14
Comcast
CMCSA
$85B
| $31.1M | 1.92% |
+1,485,400
| New | +$30.7M |
|
15
American Tower
AMT
$79.2B
| $28.1M | 1.73% |
+383,400
| New | +$30.5M |
|
16
Visa
V
$682B
| $27.3M | 1.69% |
+598,280
| New | +$26.2M |
|
17
SLB Ltd
SLB
$70.3B
| $26.2M | 1.62% |
+365,696
| New | +$27.1M |
|
18
Procter & Gamble
PG
$349B
| $26.1M | 1.61% |
+339,400
| New | +$26.6M |
|
|
MRSH
19
Marsh
MRSH
$87.8B
| $23.4M | 1.44% |
+585,900
| New | +$22.9M |
|
20
Philip Morris
PM
$301B
| $22.6M | 1.39% |
+261,050
| New | +$24.3M |
|
21
VeriSign
VRSN
$25.3B
| $21.9M | 1.35% |
+490,500
| New | +$22.7M |
|
22
Boeing
BA
$169B
| $21.3M | 1.31% |
+207,900
| New | +$19.8M |
|
23
RTX Corp
RTX
$261B
| $21.2M | 1.31% |
+363,245
| New | +$21.5M |
|
|
ESRX
24
DELISTED
Express Scripts Holding Company
ESRX
| $21.2M | 1.31% |
+344,000
| New | +$20.7M |
|
25
Starbucks
SBUX
$120B
| $20.6M | 1.27% |
+628,898
| New | +$19.5M |
|
Similar funds
HC
GIA
TPSF
LP
HCM
LSA
SFS
SCM
Capital International's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Capital International, which disclosed 161 positions worth $1.62B. Its ten largest holdings account for 33% of the portfolio.
Its largest position is Gilead Sciences: 2,482,000 shares worth $127M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, followed by Financials and Energy.
- Capital International's largest Q2 2013 buy was Gilead Sciences: 2,482,000 shares worth $127M.
- Capital International's ten largest holdings make up 33% of its $1.62B portfolio in Q2 2013.
- Capital International disclosed 161 positions in Q2 2013, its first 13F filing on record.
Based on Capital International's 13F filing for Q2 2013, filed 14 Aug 2013.